FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200296775> ?p ?o ?g. }

• W4200296775 endingPage "959" @default.
• W4200296775 startingPage "948" @default.
• W4200296775 abstract "Advances in our understanding of the contribution of aberrant glycosylation to the pro-oncogenic signaling and metastasis of tumor cells have reinvigorated the development of mucin-targeted therapies. Here, we validate the tumor-targeting ability of a novel monoclonal antibody (mAb), AR9.6, that binds MUC16 and abrogates downstream oncogenic signaling to confer a therapeutic response.The in vitro and ex vivo validation of the binding of AR9.6 to MUC16 was achieved via flow cytometry, radioligand binding assay (RBA), and immunohistochemistry (IHC). The in vivo MUC16 targeting of AR9.6 was validated by creating a 89Zr-labeled radioimmunoconjugate of the mAb and utilizing immunoPET and ex vivo biodistribution studies in xenograft models of human ovarian and pancreatic cancer.Flow cytometry, RBA, and IHC revealed that AR9.6 binds to ovarian and pancreatic cancer cells in an MUC16-dependent manner. The in vivo radiopharmacologic profile of 89Zr-labeled AR9.6 in mice bearing ovarian and pancreatic cancer xenografts confirmed the MUC16-dependent tumor targeting by the radioimmunoconjugate. Radioactivity uptake was also observed in the distant lymph nodes (LNs) of mice bearing xenografts with high levels of MUC16 expression (i.e., OVCAR3 and Capan-2). IHC analyses of these PET-positive LNs highlighted the presence of shed antigen as well as necrotic, phagocytized, and actively infiltrating neoplastic cells. The humanization of AR9.6 did not compromise its ability to target MUC16-expressing tumors.The unique therapeutic mechanism of AR9.6 combined with its excellent in vivo tumor targeting makes it a highly promising theranostic agent. huAR9.6 is poised for clinical translation to impact the management of metastatic ovarian and pancreatic cancers." @default.
• W4200296775 created "2021-12-31" @default.
• W4200296775 creator A5004111432 @default.
• W4200296775 creator A5022661924 @default.
• W4200296775 creator A5025073506 @default.
• W4200296775 creator A5026061991 @default.
• W4200296775 creator A5034390741 @default.
• W4200296775 creator A5036905769 @default.
• W4200296775 creator A5036936740 @default.
• W4200296775 creator A5042667547 @default.
• W4200296775 creator A5044367027 @default.
• W4200296775 creator A5046762590 @default.
• W4200296775 creator A5049809483 @default.
• W4200296775 creator A5058650693 @default.
• W4200296775 creator A5059090988 @default.
• W4200296775 creator A5061907500 @default.
• W4200296775 creator A5068928963 @default.
• W4200296775 creator A5084837942 @default.
• W4200296775 date "2021-12-13" @default.
• W4200296775 modified "2023-10-15" @default.
• W4200296775 title "ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody" @default.
• W4200296775 cites W1544375765 @default.
• W4200296775 cites W1967760419 @default.
• W4200296775 cites W1968178110 @default.
• W4200296775 cites W1975303054 @default.
• W4200296775 cites W1977709543 @default.
• W4200296775 cites W1985020660 @default.
• W4200296775 cites W1990157326 @default.
• W4200296775 cites W1992083261 @default.
• W4200296775 cites W2005483804 @default.
• W4200296775 cites W2016329950 @default.
• W4200296775 cites W2022462471 @default.
• W4200296775 cites W2063218301 @default.
• W4200296775 cites W2065226341 @default.
• W4200296775 cites W2075253368 @default.
• W4200296775 cites W2081249139 @default.
• W4200296775 cites W2083590898 @default.
• W4200296775 cites W2091544234 @default.
• W4200296775 cites W2100256708 @default.
• W4200296775 cites W2115269770 @default.
• W4200296775 cites W2124932273 @default.
• W4200296775 cites W2150312232 @default.
• W4200296775 cites W2176970360 @default.
• W4200296775 cites W2194340708 @default.
• W4200296775 cites W2259849752 @default.
• W4200296775 cites W2401189462 @default.
• W4200296775 cites W2405830307 @default.
• W4200296775 cites W2588980844 @default.
• W4200296775 cites W2624991967 @default.
• W4200296775 cites W2750694869 @default.
• W4200296775 cites W2789683369 @default.
• W4200296775 cites W2801530720 @default.
• W4200296775 cites W2883796806 @default.
• W4200296775 cites W2897346547 @default.
• W4200296775 cites W2902190577 @default.
• W4200296775 cites W2909703266 @default.
• W4200296775 cites W2951890667 @default.
• W4200296775 cites W2999417355 @default.
• W4200296775 cites W3008933373 @default.
• W4200296775 cites W3009903374 @default.
• W4200296775 cites W3022447026 @default.
• W4200296775 cites W3023945600 @default.
• W4200296775 cites W3038035987 @default.
• W4200296775 cites W3041255095 @default.
• W4200296775 cites W3042853117 @default.
• W4200296775 cites W3097586971 @default.
• W4200296775 cites W3116046341 @default.
• W4200296775 cites W3129148766 @default.
• W4200296775 cites W4254682436 @default.
• W4200296775 cites W4324118154 @default.
• W4200296775 doi "https://doi.org/10.1158/1078-0432.ccr-21-1798" @default.
• W4200296775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34907079" @default.
• W4200296775 hasPublicationYear "2021" @default.
• W4200296775 type Work @default.
• W4200296775 citedByCount "10" @default.
• W4200296775 countsByYear W42002967752022 @default.
• W4200296775 countsByYear W42002967752023 @default.
• W4200296775 crossrefType "journal-article" @default.
• W4200296775 hasAuthorship W4200296775A5004111432 @default.
• W4200296775 hasAuthorship W4200296775A5022661924 @default.
• W4200296775 hasAuthorship W4200296775A5025073506 @default.
• W4200296775 hasAuthorship W4200296775A5026061991 @default.
• W4200296775 hasAuthorship W4200296775A5034390741 @default.
• W4200296775 hasAuthorship W4200296775A5036905769 @default.
• W4200296775 hasAuthorship W4200296775A5036936740 @default.
• W4200296775 hasAuthorship W4200296775A5042667547 @default.
• W4200296775 hasAuthorship W4200296775A5044367027 @default.
• W4200296775 hasAuthorship W4200296775A5046762590 @default.
• W4200296775 hasAuthorship W4200296775A5049809483 @default.
• W4200296775 hasAuthorship W4200296775A5058650693 @default.
• W4200296775 hasAuthorship W4200296775A5059090988 @default.
• W4200296775 hasAuthorship W4200296775A5061907500 @default.
• W4200296775 hasAuthorship W4200296775A5068928963 @default.
• W4200296775 hasAuthorship W4200296775A5084837942 @default.
• W4200296775 hasBestOaLocation W42002967751 @default.
• W4200296775 hasConcept C121608353 @default.
• W4200296775 hasConcept C126322002 @default.
• W4200296775 hasConcept C142724271 @default.

• next